The National Institute for Health and Care Excellence has recommended #Lynparza for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or primary peritonealcancer in adults with a BRCA1 or BRCA2 mutation (see link below). NICE reported this endorsement is due to recent evidence from #clinicaltrials. Using #Kognitic's breadth of filters, our clients can access all Lynparza trials in this #patientsegment instantly! #OvarianCancer #Olaparib #Cancer #Au